Yang D - Search Results

1

High expression of tumor necrosis factor receptor 2 in tissue is associated with progression and prognosis of esophageal squamous cell carcinoma.

Liu Z, Ma C, Ma G, Sun X, Liu J, Li S, Liu K, Wang J, Yang D. Liu Z, et al. Among authors: yang d. Hum Pathol. 2018 Oct;80:179-185. doi: 10.1016/j.humpath.2018.03.027. Epub 2018 Jun 18. Hum Pathol. 2018. PMID: 29920311

2

Clinical significance of tumor necrosis factor receptor 2 in middle and lower thoracic esophageal squamous cell carcinoma.

Yang D, Li R, Wang H, Wang J, Li Y, Wang H, Wang W, Liu Z. Yang D, et al. Oncol Lett. 2018 Sep;16(3):2971-2978. doi: 10.3892/ol.2018.8998. Epub 2018 Jun 20. Oncol Lett. 2018. PMID: 30127886 Free PMC article.

3

Clinicopathological significance of fibroblast growth factor 1 in non-small cell lung cancer.

Li J, Wei Z, Li H, Dang Q, Zhang Z, Wang L, Gao W, Zhang P, Yang D, Liu J, Sun Y, Gao W. Li J, et al. Among authors: yang d. Hum Pathol. 2015 Dec;46(12):1821-8. doi: 10.1016/j.humpath.2015.07.022. Epub 2015 Aug 12. Hum Pathol. 2015. PMID: 26391572

4

Clinical implications of progranulin in gastric cancer and its regulation via a positive feedback loop involving AKT and ERK signaling pathways.

Yang D, Li R, Wang H, Wang J, Han L, Pan L, Li X, Kong Q, Wang G, Su X. Yang D, et al. Mol Med Rep. 2017 Dec;16(6):9685-9691. doi: 10.3892/mmr.2017.7796. Epub 2017 Oct 17. Mol Med Rep. 2017. PMID: 29039535

5

Progranulin promotes lymphangiogenesis through VEGF-C and is an independent risk factor in human esophageal cancers.

Li G, Dong T, Yang D, Gao A, Luo J, Yang H, Wang L. Li G, et al. Among authors: yang d, yang h. Hum Pathol. 2018 May;75:116-124. doi: 10.1016/j.humpath.2018.02.008. Epub 2018 Feb 13. Hum Pathol. 2018. PMID: 29452214

6

B7-H3 in combination with regulatory T cell is associated with tumor progression in primary human non-small cell lung cancer.

Jin Y, Zhang P, Li J, Zhao J, Liu C, Yang F, Yang D, Gao A, Lin W, Ma X, Sun Y. Jin Y, et al. Among authors: yang d, yang f. Int J Clin Exp Pathol. 2015 Nov 1;8(11):13987-95. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26823710 Free PMC article.

7

Co-expression of podoplanin and fibroblast growth factor 1 predicts poor prognosis in patients with lung squamous cell carcinoma.

Li J, Chen H, Li X, Wang L, Gao A, Zhang P, Lin W, Gao W, Yang D, Guo X, Liu J, Dang Q, Sun Y. Li J, et al. Among authors: yang d. Mol Med Rep. 2017 Aug;16(2):1643-1652. doi: 10.3892/mmr.2017.6830. Epub 2017 Jun 21. Mol Med Rep. 2017. PMID: 28656229 Free PMC article.

8

Co-expression of ILT4/HLA-G in human non-small cell lung cancer correlates with poor prognosis and ILT4-HLA-G interaction activates ERK signaling.

Zhang Y, Zhao J, Qiu L, Zhang P, Li J, Yang D, Wei X, Han Y, Nie S, Sun Y. Zhang Y, et al. Among authors: yang d. Tumour Biol. 2016 Aug;37(8):11187-98. doi: 10.1007/s13277-016-5002-5. Epub 2016 Mar 3. Tumour Biol. 2016. PMID: 26939901

9

Tumor necrosis factor receptor 2/AKT and ERK signaling pathways contribute to the switch from fibroblasts to CAFs by progranulin in microenvironment of colorectal cancer.

Wang L, Yang D, Tian J, Gao A, Shen Y, Ren X, Li X, Jiang G, Dong T. Wang L, et al. Among authors: yang d. Oncotarget. 2017 Apr 18;8(16):26323-26333. doi: 10.18632/oncotarget.15461. Oncotarget. 2017. PMID: 28412748 Free PMC article.

10

The SMYD3 VNTR 3/3 polymorphism confers an increased risk and poor prognosis of hepatocellular carcinoma in a Chinese population.

Li RD, Tang YH, Wang HL, Yang D, Sun LJ, Li W. Li RD, et al. Among authors: yang d. Pathol Res Pract. 2018 May;214(5):625-630. doi: 10.1016/j.prp.2018.04.005. Epub 2018 Apr 17. Pathol Res Pract. 2018. PMID: 29691085

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24,284 results

Search Page

Filters